Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: a NLCS and CIBMTR Analysis.

about

Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: a NLCS and CIBMTR Analysis.

Item

http://www.wikidata.org/entity/Q45875848

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Autologous Transplantation in ...... e: a NLCS and CIBMTR Analysis.

@en

Autologous Transplantation in ...... e: a NLCS and CIBMTR Analysis.

@nl

type

Item

label

Autologous Transplantation in ...... e: a NLCS and CIBMTR Analysis.

@en

Autologous Transplantation in ...... e: a NLCS and CIBMTR Analysis.

@nl

prefLabel

Autologous Transplantation in ...... e: a NLCS and CIBMTR Analysis.

@en

Autologous Transplantation in ...... e: a NLCS and CIBMTR Analysis.

@nl

P1476

Autologous Transplantation in ...... w Transplant Research Analysis

@en

P2093

Aaron Cumpston

http://www.w3.org/2001/XMLSchema#string

Aleksandr Lazaryan

http://www.w3.org/2001/XMLSchema#string

Alyssa DiGilio

http://www.w3.org/2001/XMLSchema#string

Andrew D Zelenetz

http://www.w3.org/2001/XMLSchema#string

Andrew R Rezvani

http://www.w3.org/2001/XMLSchema#string

Andy I Chen

http://www.w3.org/2001/XMLSchema#string

Anna Sureda

http://www.w3.org/2001/XMLSchema#string

Basem William

http://www.w3.org/2001/XMLSchema#string

Carla Casulo

http://www.w3.org/2001/XMLSchema#string

Cesar Freytes

http://www.w3.org/2001/XMLSchema#string

P2860

Transformed follicular non-Hodgkin lymphoma

Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial.

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma.

Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation

Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus (131)iodine-tositumomab for previously untreated follicular non-Hodgkin lymphoma: SWOG S0016.

Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study.

P304

1163-1171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2017.12.771

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29242111

http://www.w3.org/2001/XMLSchema#string

P932

5993598

http://www.w3.org/2001/XMLSchema#string